Pediatric erosive esophagitis maintenance: finally, some level 1 evidence!

Area of Science:

• Pediatric Gastroenterology
• Clinical Therapeutics
• Chronic Disease Management

Background:

• Gastroesophageal reflux disease (GERD), including erosive esophagitis, is often presumed to be a chronic condition in children, necessitating long-term proton pump inhibitor (PPI) maintenance therapy.
• This assumption, however, lacks robust clinical validation, prompting critical re-evaluation of standard treatment protocols for pediatric GERD.

Discussion:

• A prospective, randomized controlled study challenges the chronic nature of GERD in children without significant comorbidities.
• The findings suggest that long-term PPI use might induce a state of PPI dependence rather than reflecting inherent GERD chronicity in otherwise healthy children.
• Limitations include the study's limited statistical power and the absence of validated outcome measures, restricting generalizability.

Key Insights:

• The study indicates that GERD in otherwise healthy children may not be a chronic disease requiring lifelong PPIs.
• Proton pump inhibitor (PPI) dependence could be an iatrogenic effect of prolonged treatment, not a consequence of disease chronicity.
• This challenges the established paradigm of lifelong maintenance therapy for pediatric GERD.

Outlook:

• Further research with larger cohorts and validated outcome measures is needed to confirm these provocative findings.
• Clinical practice guidelines for pediatric GERD may require revision, particularly concerning the duration and necessity of chronic PPI therapy.
• Investigating alternative, non-pharmacological interventions for pediatric GERD could become a priority.